RARECast: Why Genomics May Be in Google’s DNA
August 7, 2015
The Internet giant Google has set its sights on revolutionizing how researchers store, analyze, and share genomic data. The company recently entered into an agreement with the Broad Institute that allows it to integrate Broad’s Genomic Analysis Toolkit into Google Genomics. We spoke to David Glazer, director of engineering for Google, about its Google Genomics platform, the opportunity it sees in genomics, and what it’s doing to help researchers turn vast amounts of data into actionable information.
David Glazer will be speaking at the 2015 Patient Advocacy Summit about how patients can learn first-hand how Google Genomics is revolutionizing how we can store, process, explore, and share genomic data. Be the first to hear why this holds untold promise for identifying patients, spurring research, and finding new answers for rare disease patients and their communities.
RARECast is a weekly series by Daniel S. Levine. Levine is an award-winning business journalist who has reported on the life sciences, economic development, and business policy issues throughout his 25-year career. He founded Levine Media Group in 2013, which produces The Bio Report and RARECast podcasts. Read his full bio here.
Sign up for updates straight to your inbox.